Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Patients feeling severely affected by multiple sclerosis: How do patients want to communicate about end-of-life issues?
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
NAD⁺ in aging, metabolism, and neurodegeneration.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
Tocilizumab, MS, and NMOSD.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Is multiple sclerosis a proresolution deficiency disorder?
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
Epidural blood patch in a patient with multiple sclerosis: is it safe?
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Rehabilitation in transverse myelitis.
Natalizumab in the treatment of rheumatoid arthritis in subjects receiving methotrexate
Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab.

Pages